XLV ranks 1st and KURE 23rd of 25 funds in the Health Care (Broad) Category.
KURE vs XLV
XLV −0.57pt a year
0.65%0.08%
XLV 112.7×the volume
80.8K9.1M
XLV +17.6pt
−9.3%+8.3%
KURE vs XLV Performance
−38.5%+48.8%
- KURE 0.65%
- XLV 0.08%, better
- KURE $108M
- XLV $48.5B
- KURE −6.6%
- XLV +30.1%, better
- KURE 4.12%, better
- XLV 1.38%
- KURE 44
- XLV 64
- KURE 80.8K sh
- XLV 9.1M sh, better
- KURE $17.55
- XLV $184.09
ETF.net Grade
| Pillar | KURE | XLV |
|---|---|---|
| Cost | D27 | A98Higher |
| Mission | A84 | |
| Risk | F9 | A78Higher |
| Tradability | F24 | A100Higher |
| Holdings | C52Higher | D39 |
| Durability | D36 | A87Higher |
Rank among Health Care (Broad) funds
Same Category. KURE and XLV are both graded against the same 25 Health Care (Broad) funds, so their Grades compare head to head.
Our read on each fund
KURED
XLVA
In short
KURE The US-listed route into China's health care sector in one ticker: about 50 Chinese pharma and medical names listed in the Mainland, Hong Kong and the US. A narrow, volatile slice of a huge market, not a broad pharma fund.
XLV Live since 1998, XLV is the original way to own health care: about 60 S&P 500 names, a 0.08% fee, and one of the busiest tickers in the sector. Big pharma and device makers, not small-cap biotech.
Stated mandate
KURE KURE is designed to track the MSCI China All Shares Healthcare 10/40 Index, which represents Chinese companies engaged in the healthcare sector.
XLV The fund seeks to track, before expenses, the price and yield performance of the Health Care Select Sector Index, which represents the health care sector of the S&P 500 Index.
Why people hold it
Worth knowing
KURE vs XLV Holdings
How we measure overlap
Each holding counts at its smaller weight in the two funds, summed over the full Holdings. Sector, country and asset class use the same rule on each fund’s split. Cash, FX and derivative lines stay out of the counts. Two bond funds get no overlap figure.
KURE vs XLV Cost
Overpaying KURE vs XLV
$11,028
On $10,000 over 30 years. 7% growth a year before fees, expense ratio only.
KURE 0.65%
$12,717
XLV 0.08%
$1,689
Cost over time
Year by year
| Year | KURE | XLV | Overpaying |
|---|---|---|---|
| 10 | $1,163 | $147 | $1,016 |
| 20 | $4,440 | $575 | $3,865 |
| 30 | $12,717 | $1,689 | $11,028 |
- 0.65%KURE
- 0.08%XLV, cheaper
- Middle half of Health Care (Broad) funds
- Median 0.50%
XLV cheapest of 25 funds
KURE 18th cheapest of 25 funds
KURE vs XLV Dividends
- KURE 4.12%, better
- XLV 1.38%
- KURE $0.71
- XLV $2.55
- KURE $0.71
- XLV $0.64
- KURE Dec 22, 2025
- XLV Sep 21, 2026
- KURE Dec 23, 2025
- XLV Sep 23, 2026
- KURE Annual
- XLV Quarterly
Distribution history
KURE vs XLV Risk
Fall from peak · 5 years
- KURE
- XLV
Risk facts
- Volatility
- KURE 26.5%XLV 14.8%, better
- Return per unit of risk
- KURE −0.02XLV 0.78, better
- Worst fall
- KURE −58.6%XLV −17.1%, better
- Market sensitivity
- KURE 0.30XLV 0.56
KURE and XLV in the news
Popular comparisons
- 0.65% · 0.08%
- Same Category. Both funds are graded against the same funds, so their Grades compare head to head.
- 0.08% · 0.08%
- Same Category. Both funds are graded against the same funds, so their Grades compare head to head.
- 0.65% · 0.09%
- Same Category. Both funds are graded against the same funds, so their Grades compare head to head.
- 0.08% · 0.09%
- Same Category. Both funds are graded against the same funds, so their Grades compare head to head.
- 0.65% · 0.35%
- Same Category. Both funds are graded against the same funds, so their Grades compare head to head.
- 0.08% · 0.35%
- Same Category. Both funds are graded against the same funds, so their Grades compare head to head.





